

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.41719884 |
| 2 | * L-phenylalanine catabolic process (GO:0006559) | 7.41719884 |
| 3 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.09922671 |
| 4 | * L-phenylalanine metabolic process (GO:0006558) | 7.09922671 |
| 5 | * aromatic amino acid family catabolic process (GO:0009074) | 6.84900281 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.58400513 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.38927944 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.38927944 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.38927944 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.15157874 |
| 11 | omega-hydroxylase P450 pathway (GO:0097267) | 6.11436629 |
| 12 | glyoxylate metabolic process (GO:0046487) | 6.08849199 |
| 13 | tryptophan metabolic process (GO:0006568) | 6.00723098 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.97900811 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.92640497 |
| 16 | cysteine metabolic process (GO:0006534) | 5.73367675 |
| 17 | urea metabolic process (GO:0019627) | 5.62962279 |
| 18 | urea cycle (GO:0000050) | 5.62962279 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.44501841 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.43195043 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.33617509 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 5.32341838 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.26743353 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 5.19238018 |
| 25 | lysine catabolic process (GO:0006554) | 5.17285180 |
| 26 | lysine metabolic process (GO:0006553) | 5.17285180 |
| 27 | regulation of plasminogen activation (GO:0010755) | 5.17182677 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.13171972 |
| 29 | protein carboxylation (GO:0018214) | 5.13171972 |
| 30 | regulation of fibrinolysis (GO:0051917) | 5.12525031 |
| 31 | complement activation, alternative pathway (GO:0006957) | 5.11735562 |
| 32 | homocysteine metabolic process (GO:0050667) | 5.08503361 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.06475722 |
| 34 | regulation of protein activation cascade (GO:2000257) | 5.06133459 |
| 35 | bile acid metabolic process (GO:0008206) | 5.01769763 |
| 36 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.96192624 |
| 37 | intestinal cholesterol absorption (GO:0030299) | 4.94351835 |
| 38 | * aromatic amino acid family metabolic process (GO:0009072) | 4.92006847 |
| 39 | negative regulation of hemostasis (GO:1900047) | 4.86766128 |
| 40 | negative regulation of blood coagulation (GO:0030195) | 4.86766128 |
| 41 | protein activation cascade (GO:0072376) | 4.81700503 |
| 42 | drug metabolic process (GO:0017144) | 4.79842747 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.78897344 |
| 44 | regulation of complement activation (GO:0030449) | 4.73300964 |
| 45 | * alpha-amino acid catabolic process (GO:1901606) | 4.72277056 |
| 46 | negative regulation of protein activation cascade (GO:2000258) | 4.65197424 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.63118622 |
| 48 | regulation of cholesterol esterification (GO:0010872) | 4.61198738 |
| 49 | reverse cholesterol transport (GO:0043691) | 4.57435795 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 4.55630715 |
| 51 | indolalkylamine metabolic process (GO:0006586) | 4.52282191 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.51321890 |
| 53 | protein-lipid complex remodeling (GO:0034368) | 4.51321890 |
| 54 | macromolecular complex remodeling (GO:0034367) | 4.51321890 |
| 55 | negative regulation of coagulation (GO:0050819) | 4.48962888 |
| 56 | positive regulation of blood coagulation (GO:0030194) | 4.47471357 |
| 57 | positive regulation of hemostasis (GO:1900048) | 4.47471357 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.46782109 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.46782109 |
| 60 | acylglycerol homeostasis (GO:0055090) | 4.44232070 |
| 61 | triglyceride homeostasis (GO:0070328) | 4.44232070 |
| 62 | glycine metabolic process (GO:0006544) | 4.42597260 |
| 63 | glutamate metabolic process (GO:0006536) | 4.41565516 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 4.41411216 |
| 65 | amine catabolic process (GO:0009310) | 4.41411216 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 4.41171910 |
| 67 | * cellular amino acid catabolic process (GO:0009063) | 4.37888577 |
| 68 | ethanol metabolic process (GO:0006067) | 4.36741581 |
| 69 | coenzyme catabolic process (GO:0009109) | 4.36727081 |
| 70 | plasma lipoprotein particle organization (GO:0071827) | 4.33105960 |
| 71 | regulation of humoral immune response (GO:0002920) | 4.33059303 |
| 72 | acute-phase response (GO:0006953) | 4.32207360 |
| 73 | negative regulation of wound healing (GO:0061045) | 4.31119942 |
| 74 | phospholipid efflux (GO:0033700) | 4.29954000 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 4.28226765 |
| 76 | bile acid and bile salt transport (GO:0015721) | 4.26271003 |
| 77 | cellular glucuronidation (GO:0052695) | 4.24422571 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 4.24169111 |
| 79 | phenylpropanoid metabolic process (GO:0009698) | 4.23076634 |
| 80 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.22964533 |
| 81 | drug catabolic process (GO:0042737) | 4.22495676 |
| 82 | oxidative demethylation (GO:0070989) | 4.21165443 |
| 83 | imidazole-containing compound metabolic process (GO:0052803) | 4.19684123 |
| 84 | * tyrosine metabolic process (GO:0006570) | 4.18435621 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 4.18278557 |
| 86 | plasma lipoprotein particle clearance (GO:0034381) | 4.15764598 |
| 87 | positive regulation of coagulation (GO:0050820) | 4.15240676 |
| 88 | complement activation (GO:0006956) | 4.13909557 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.10942976 |
| 90 | ethanol oxidation (GO:0006069) | 4.10317678 |
| 91 | doxorubicin metabolic process (GO:0044598) | 4.10287560 |
| 92 | daunorubicin metabolic process (GO:0044597) | 4.10287560 |
| 93 | polyketide metabolic process (GO:0030638) | 4.10287560 |
| 94 | aldehyde catabolic process (GO:0046185) | 4.09965466 |
| 95 | protein-lipid complex subunit organization (GO:0071825) | 4.06561454 |
| 96 | urate metabolic process (GO:0046415) | 4.05482264 |
| 97 | arginine metabolic process (GO:0006525) | 4.03387798 |
| 98 | protein-lipid complex assembly (GO:0065005) | 4.02803726 |
| 99 | drug transmembrane transport (GO:0006855) | 4.00071171 |
| 100 | cholesterol efflux (GO:0033344) | 3.95510346 |
| 101 | short-chain fatty acid metabolic process (GO:0046459) | 3.95011571 |
| 102 | ketone body metabolic process (GO:1902224) | 3.94380928 |
| 103 | acetyl-CoA metabolic process (GO:0006084) | 3.89704967 |
| 104 | fibrinolysis (GO:0042730) | 3.84585636 |
| 105 | * carboxylic acid catabolic process (GO:0046395) | 3.83959758 |
| 106 | * organic acid catabolic process (GO:0016054) | 3.83959758 |
| 107 | uronic acid metabolic process (GO:0006063) | 3.82000635 |
| 108 | glucuronate metabolic process (GO:0019585) | 3.82000635 |
| 109 | aspartate family amino acid catabolic process (GO:0009068) | 3.80225693 |
| 110 | negative regulation of complement activation (GO:0045916) | 3.78094981 |
| 111 | low-density lipoprotein particle remodeling (GO:0034374) | 3.77030101 |
| 112 | plasma lipoprotein particle assembly (GO:0034377) | 3.76599449 |
| 113 | exogenous drug catabolic process (GO:0042738) | 3.74623346 |
| 114 | cytolysis (GO:0019835) | 3.72755696 |
| 115 | regulation of apoptotic cell clearance (GO:2000425) | 3.71996126 |
| 116 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.71111664 |
| 117 | regulation of bile acid biosynthetic process (GO:0070857) | 3.70755803 |
| 118 | cofactor catabolic process (GO:0051187) | 3.70616703 |
| 119 | 2-oxoglutarate metabolic process (GO:0006103) | 3.68007843 |
| 120 | regulation of cholesterol homeostasis (GO:2000188) | 3.65942553 |
| 121 | S-adenosylmethionine metabolic process (GO:0046500) | 3.65810171 |
| 122 | phospholipid homeostasis (GO:0055091) | 3.62569385 |
| 123 | cholesterol homeostasis (GO:0042632) | 3.62406816 |
| 124 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.60954409 |
| 125 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.60954409 |
| 126 | blood coagulation, intrinsic pathway (GO:0007597) | 3.60808360 |
| 127 | sterol homeostasis (GO:0055092) | 3.57976729 |
| 128 | opsonization (GO:0008228) | 3.57567606 |
| 129 | positive regulation of lipid catabolic process (GO:0050996) | 3.57482027 |
| 130 | complement activation, classical pathway (GO:0006958) | 3.56953893 |
| 131 | NAD biosynthetic process (GO:0009435) | 3.55935035 |
| 132 | negative regulation of lipase activity (GO:0060192) | 3.55601987 |
| 133 | monocarboxylic acid catabolic process (GO:0072329) | 3.55036965 |
| 134 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.54633270 |
| 135 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.54520341 |
| 136 | flavonoid metabolic process (GO:0009812) | 3.53305397 |
| 137 | lipoprotein metabolic process (GO:0042157) | 3.50822016 |
| 138 | sterol transport (GO:0015918) | 3.47744556 |
| 139 | cholesterol transport (GO:0030301) | 3.47744556 |
| 140 | acute inflammatory response (GO:0002526) | 3.44555381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.37452222 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18516961 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.84524905 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.46021671 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.22450786 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.98525504 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.88948110 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.01334285 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.96745786 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.09015966 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07908995 |
| 12 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07416141 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8357269 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61814535 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60090010 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.45378006 |
| 17 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44110045 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35338782 |
| 19 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.33798094 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32853191 |
| 21 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.31899155 |
| 22 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.26488792 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21289929 |
| 24 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18517756 |
| 25 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17804836 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05987606 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04555707 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02713694 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01885294 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00584824 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97182496 |
| 32 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96297681 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94665876 |
| 34 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92740201 |
| 35 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.90316379 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89052622 |
| 37 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86616912 |
| 38 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86235752 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86092291 |
| 40 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85826838 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.85370032 |
| 42 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.83914099 |
| 43 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82922816 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82791961 |
| 45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80465953 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79463852 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77849182 |
| 48 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77134809 |
| 49 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76854381 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76354410 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75349210 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.73500815 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73333801 |
| 54 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72546804 |
| 55 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71512325 |
| 56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71449384 |
| 57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70889589 |
| 58 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.70639767 |
| 59 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.70320185 |
| 60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.70019289 |
| 61 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69930758 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.69715334 |
| 63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68596192 |
| 64 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.68555970 |
| 65 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67739459 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65896456 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65896456 |
| 68 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.65776600 |
| 69 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.65507336 |
| 70 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.64476533 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.64107047 |
| 72 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63904465 |
| 73 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63889115 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63588132 |
| 75 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.63445687 |
| 76 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.63298263 |
| 77 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.61932109 |
| 78 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61365589 |
| 79 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.61154972 |
| 80 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60867361 |
| 81 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.60678953 |
| 82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.59532499 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58849963 |
| 84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58790645 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57804584 |
| 86 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.57669506 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.56337647 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.56131513 |
| 89 | TP53_16413492_ChIP-PET_HCT116_Human | 0.55784804 |
| 90 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.55652228 |
| 91 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.55116890 |
| 92 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54515689 |
| 93 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.54407284 |
| 94 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54394058 |
| 95 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.54326797 |
| 96 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.53586220 |
| 97 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.53174539 |
| 98 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.52780898 |
| 99 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.52217640 |
| 100 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51981642 |
| 101 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51321311 |
| 102 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50581171 |
| 103 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50024857 |
| 104 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49688611 |
| 105 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48875471 |
| 106 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.48438395 |
| 107 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48073025 |
| 108 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46048858 |
| 109 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.45519694 |
| 110 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45359920 |
| 111 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44839279 |
| 112 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.44208051 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43650490 |
| 114 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.43447799 |
| 115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.41977205 |
| 116 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41894866 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41780399 |
| 118 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41689359 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.41610299 |
| 120 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41548363 |
| 121 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41206052 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41203763 |
| 123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41046037 |
| 124 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.39713510 |
| 125 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.39309851 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38694211 |
| 127 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38654151 |
| 128 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38621117 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37451750 |
| 130 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37079739 |
| 131 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.36603416 |
| 132 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36386274 |
| 133 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36179479 |
| 134 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35851333 |
| 135 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.35781925 |
| 136 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.35651718 |
| 137 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.35546089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.24351852 |
| 2 | MP0005360_urolithiasis | 7.85853962 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.29448607 |
| 4 | MP0005365_abnormal_bile_salt | 6.06578430 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.09254037 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.14119354 |
| 7 | MP0003252_abnormal_bile_duct | 3.92323807 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.42697580 |
| 9 | MP0003195_calcinosis | 3.08662062 |
| 10 | MP0009840_abnormal_foam_cell | 3.07614701 |
| 11 | * MP0005332_abnormal_amino_acid | 2.99754127 |
| 12 | MP0005083_abnormal_biliary_tract | 2.86817424 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.53745078 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.46921438 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.27446037 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.22314721 |
| 17 | MP0000609_abnormal_liver_physiology | 2.09219591 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.05509790 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.84884267 |
| 20 | MP0003868_abnormal_feces_composition | 1.82998818 |
| 21 | MP0001764_abnormal_homeostasis | 1.69941860 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62758365 |
| 23 | MP0002132_abnormal_respiratory_system | 1.53435703 |
| 24 | MP0005451_abnormal_body_composition | 1.50564895 |
| 25 | * MP0009643_abnormal_urine_homeostasis | 1.47827297 |
| 26 | MP0009697_abnormal_copulation | 1.41877583 |
| 27 | MP0003186_abnormal_redox_activity | 1.37367222 |
| 28 | MP0003011_delayed_dark_adaptation | 1.26273501 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.16224673 |
| 30 | MP0005636_abnormal_mineral_homeostasis | 1.15737231 |
| 31 | MP0000598_abnormal_liver_morphology | 1.15494342 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.08698931 |
| 33 | MP0003879_abnormal_hair_cell | 1.07541836 |
| 34 | MP0005647_abnormal_sex_gland | 1.07406035 |
| 35 | MP0009764_decreased_sensitivity_to | 1.05330424 |
| 36 | MP0000604_amyloidosis | 1.01923394 |
| 37 | MP0001915_intracranial_hemorrhage | 0.99636046 |
| 38 | MP0009763_increased_sensitivity_to | 0.96004922 |
| 39 | MP0002254_reproductive_system_inflammat | 0.90184937 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 0.89720593 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.88720053 |
| 42 | MP0008469_abnormal_protein_level | 0.88632313 |
| 43 | MP0003122_maternal_imprinting | 0.88421922 |
| 44 | MP0005670_abnormal_white_adipose | 0.85746736 |
| 45 | MP0001756_abnormal_urination | 0.85401910 |
| 46 | MP0002876_abnormal_thyroid_physiology | 0.85250611 |
| 47 | MP0005408_hypopigmentation | 0.84932014 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 0.84383516 |
| 49 | MP0010368_abnormal_lymphatic_system | 0.82613558 |
| 50 | MP0005376_homeostasis/metabolism_phenot | 0.77935748 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 0.76559902 |
| 52 | MP0009765_abnormal_xenobiotic_induced | 0.75495787 |
| 53 | MP0005220_abnormal_exocrine_pancreas | 0.73638084 |
| 54 | MP0005535_abnormal_body_temperature | 0.72948991 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 0.71378119 |
| 56 | MP0001661_extended_life_span | 0.70298911 |
| 57 | MP0004043_abnormal_pH_regulation | 0.69702722 |
| 58 | MP0002136_abnormal_kidney_physiology | 0.69449271 |
| 59 | MP0002971_abnormal_brown_adipose | 0.69277524 |
| 60 | MP0002089_abnormal_postnatal_growth/wei | 0.67080207 |
| 61 | MP0005334_abnormal_fat_pad | 0.64735254 |
| 62 | MP0002909_abnormal_adrenal_gland | 0.63683712 |
| 63 | MP0003690_abnormal_glial_cell | 0.63370070 |
| 64 | MP0004130_abnormal_muscle_cell | 0.62920582 |
| 65 | MP0003329_amyloid_beta_deposits | 0.62913825 |
| 66 | MP0005266_abnormal_metabolism | 0.62473935 |
| 67 | MP0005023_abnormal_wound_healing | 0.62245875 |
| 68 | MP0009053_abnormal_anal_canal | 0.60750852 |
| 69 | MP0005164_abnormal_response_to | 0.60416277 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 0.58918898 |
| 71 | MP0010386_abnormal_urinary_bladder | 0.58263452 |
| 72 | MP0003183_abnormal_peptide_metabolism | 0.57128456 |
| 73 | MP0005187_abnormal_penis_morphology | 0.55028740 |
| 74 | MP0000566_synostosis | 0.54754863 |
| 75 | MP0002928_abnormal_bile_duct | 0.54515409 |
| 76 | MP0000639_abnormal_adrenal_gland | 0.52052203 |
| 77 | MP0005395_other_phenotype | 0.51564997 |
| 78 | MP0003638_abnormal_response/metabolism_ | 0.50909128 |
| 79 | MP0004272_abnormal_basement_membrane | 0.50095182 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.49524141 |
| 81 | MP0005448_abnormal_energy_balance | 0.48645972 |
| 82 | MP0005410_abnormal_fertilization | 0.47917866 |
| 83 | MP0001765_abnormal_ion_homeostasis | 0.47475161 |
| 84 | MP0005646_abnormal_pituitary_gland | 0.47406874 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.45414824 |
| 86 | MP0005464_abnormal_platelet_physiology | 0.45115060 |
| 87 | MP0005409_darkened_coat_color | 0.44453441 |
| 88 | MP0008874_decreased_physiological_sensi | 0.43784712 |
| 89 | MP0003724_increased_susceptibility_to | 0.42811463 |
| 90 | MP0003718_maternal_effect | 0.42730759 |
| 91 | MP0008873_increased_physiological_sensi | 0.42495532 |
| 92 | MP0005666_abnormal_adipose_tissue | 0.42451480 |
| 93 | MP0003953_abnormal_hormone_level | 0.41572565 |
| 94 | MP0002822_catalepsy | 0.41542718 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.41323724 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.41115598 |
| 97 | MP0005058_abnormal_lysosome_morphology | 0.40072910 |
| 98 | MP0002168_other_aberrant_phenotype | 0.39875104 |
| 99 | MP0003075_altered_response_to | 0.39376086 |
| 100 | MP0002282_abnormal_trachea_morphology | 0.39359807 |
| 101 | MP0002837_dystrophic_cardiac_calcinosis | 0.38650597 |
| 102 | MP0008004_abnormal_stomach_pH | 0.38265377 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 0.37988942 |
| 104 | MP0001944_abnormal_pancreas_morphology | 0.37941474 |
| 105 | MP0005166_decreased_susceptibility_to | 0.37893114 |
| 106 | MP0009672_abnormal_birth_weight | 0.37036189 |
| 107 | MP0005379_endocrine/exocrine_gland_phen | 0.37033717 |
| 108 | MP0002796_impaired_skin_barrier | 0.36516098 |
| 109 | MP0008872_abnormal_physiological_respon | 0.36420392 |
| 110 | MP0003436_decreased_susceptibility_to | 0.36265865 |
| 111 | MP0001851_eye_inflammation | 0.33678528 |
| 112 | MP0009785_altered_susceptibility_to | 0.33143014 |
| 113 | MP0005248_abnormal_Harderian_gland | 0.32642427 |
| 114 | MP0004381_abnormal_hair_follicle | 0.31226071 |
| 115 | MP0009115_abnormal_fat_cell | 0.30694401 |
| 116 | MP0002135_abnormal_kidney_morphology | 0.30476402 |
| 117 | MP0009384_cardiac_valve_regurgitation | 0.29555657 |
| 118 | MP0000579_abnormal_nail_morphology | 0.29351866 |
| 119 | MP0006082_CNS_inflammation | 0.29338589 |
| 120 | MP0001845_abnormal_inflammatory_respons | 0.28498724 |
| 121 | MP0010155_abnormal_intestine_physiology | 0.28498474 |
| 122 | MP0006054_spinal_hemorrhage | 0.28486812 |
| 123 | MP0000249_abnormal_blood_vessel | 0.28024382 |
| 124 | MP0000538_abnormal_urinary_bladder | 0.27863424 |
| 125 | MP0002970_abnormal_white_adipose | 0.27591370 |
| 126 | MP0001243_abnormal_dermal_layer | 0.25231350 |
| 127 | MP0004264_abnormal_extraembryonic_tissu | 0.24170701 |
| 128 | MP0004883_abnormal_blood_vessel | 0.23822633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.40253161 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.07032463 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.01126925 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.56433629 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.13821274 |
| 6 | Xanthomatosis (HP:0000991) | 6.13592404 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.05067559 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.29443904 |
| 9 | Complement deficiency (HP:0004431) | 5.08500370 |
| 10 | Hyperammonemia (HP:0001987) | 4.73204734 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.63974276 |
| 12 | Joint hemorrhage (HP:0005261) | 4.59427101 |
| 13 | Hyperglycinemia (HP:0002154) | 4.58199875 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.51244152 |
| 15 | Ketosis (HP:0001946) | 4.48313265 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.39867476 |
| 17 | Hyperglycinuria (HP:0003108) | 4.39036187 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.37684387 |
| 19 | Epidermoid cyst (HP:0200040) | 4.32204237 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 4.25762059 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.25762059 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.20961761 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.18421378 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.12934696 |
| 25 | Purpura (HP:0000979) | 4.06456239 |
| 26 | Fat malabsorption (HP:0002630) | 4.00348995 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.94132061 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.85449043 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.82720769 |
| 30 | Abnormality of complement system (HP:0005339) | 3.68486398 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.58490000 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.57170845 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.53867992 |
| 34 | Nephritis (HP:0000123) | 3.48949184 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.39940217 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.38336187 |
| 37 | Ketoacidosis (HP:0001993) | 3.37049522 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33607088 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.32267110 |
| 40 | Gout (HP:0001997) | 3.27814828 |
| 41 | Hyperbilirubinemia (HP:0002904) | 3.27326954 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.18987943 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 3.14779759 |
| 44 | Steatorrhea (HP:0002570) | 3.02647298 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 3.00695226 |
| 46 | Increased mean platelet volume (HP:0011877) | 2.98744562 |
| 47 | Metabolic acidosis (HP:0001942) | 2.94723255 |
| 48 | Epistaxis (HP:0000421) | 2.90542056 |
| 49 | Spontaneous abortion (HP:0005268) | 2.79249019 |
| 50 | Myocardial infarction (HP:0001658) | 2.78956610 |
| 51 | Lethargy (HP:0001254) | 2.77491075 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.76857922 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.76857922 |
| 54 | Hypochromic microcytic anemia (HP:0004840) | 2.72503791 |
| 55 | Abnormal platelet volume (HP:0011876) | 2.69759863 |
| 56 | Skin nodule (HP:0200036) | 2.65333705 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.65244571 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.63551560 |
| 59 | Spastic diplegia (HP:0001264) | 2.54422782 |
| 60 | Cerebral edema (HP:0002181) | 2.52245166 |
| 61 | Irritability (HP:0000737) | 2.49283205 |
| 62 | Neonatal onset (HP:0003623) | 2.48948238 |
| 63 | Generalized aminoaciduria (HP:0002909) | 2.46684033 |
| 64 | Alkalosis (HP:0001948) | 2.44630497 |
| 65 | Malnutrition (HP:0004395) | 2.41804309 |
| 66 | Osteomalacia (HP:0002749) | 2.39580868 |
| 67 | Hypoglycemic seizures (HP:0002173) | 2.38081455 |
| 68 | Acanthocytosis (HP:0001927) | 2.34081851 |
| 69 | Abnormal gallbladder morphology (HP:0012437) | 2.33373839 |
| 70 | Proximal tubulopathy (HP:0000114) | 2.32521860 |
| 71 | Glomerulonephritis (HP:0000099) | 2.30739756 |
| 72 | Enlarged kidneys (HP:0000105) | 2.30700998 |
| 73 | Hyperuricemia (HP:0002149) | 2.29445035 |
| 74 | Increased purine levels (HP:0004368) | 2.29445035 |
| 75 | Vomiting (HP:0002013) | 2.28799023 |
| 76 | Cholelithiasis (HP:0001081) | 2.27945862 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 2.24191387 |
| 78 | Abnormal gallbladder physiology (HP:0012438) | 2.22055684 |
| 79 | Cholecystitis (HP:0001082) | 2.22055684 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19616592 |
| 81 | Abnormal platelet function (HP:0011869) | 2.19477590 |
| 82 | Impaired platelet aggregation (HP:0003540) | 2.19477590 |
| 83 | Late onset (HP:0003584) | 2.19076671 |
| 84 | Pancreatitis (HP:0001733) | 2.18593649 |
| 85 | Rickets (HP:0002748) | 2.17658970 |
| 86 | Abnormality of proline metabolism (HP:0010907) | 2.15305717 |
| 87 | Hydroxyprolinuria (HP:0003080) | 2.15305717 |
| 88 | Esophageal varix (HP:0002040) | 2.13292852 |
| 89 | Amyloidosis (HP:0011034) | 2.12890725 |
| 90 | Pulmonary embolism (HP:0002204) | 2.12285984 |
| 91 | * Vascular calcification (HP:0004934) | 2.08866212 |
| 92 | Brushfield spots (HP:0001088) | 2.07284010 |
| 93 | Menorrhagia (HP:0000132) | 2.03577493 |
| 94 | Opisthotonus (HP:0002179) | 2.03417212 |
| 95 | Thrombophlebitis (HP:0004418) | 2.02045327 |
| 96 | Fair hair (HP:0002286) | 2.01644934 |
| 97 | Abnormality of urine glucose concentration (HP:0011016) | 2.01475761 |
| 98 | Glycosuria (HP:0003076) | 2.01475761 |
| 99 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.00281559 |
| 100 | Gingival bleeding (HP:0000225) | 1.99609158 |
| 101 | Hypophosphatemic rickets (HP:0004912) | 1.96257017 |
| 102 | Abnormal tarsal ossification (HP:0008369) | 1.95582179 |
| 103 | Increased serum ferritin (HP:0003281) | 1.94242160 |
| 104 | Abnormality of the gallbladder (HP:0005264) | 1.93439265 |
| 105 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.91967076 |
| 106 | Hemorrhage of the eye (HP:0011885) | 1.89503577 |
| 107 | * Joint swelling (HP:0001386) | 1.87000417 |
| 108 | Renal cortical cysts (HP:0000803) | 1.85783905 |
| 109 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84020118 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 1.82704298 |
| 111 | Poikilocytosis (HP:0004447) | 1.82648655 |
| 112 | Hyperphosphaturia (HP:0003109) | 1.81953236 |
| 113 | Elevated hepatic transaminases (HP:0002910) | 1.80629090 |
| 114 | Status epilepticus (HP:0002133) | 1.79950962 |
| 115 | Abnormality of vitamin metabolism (HP:0100508) | 1.79168281 |
| 116 | Elevated alkaline phosphatase (HP:0003155) | 1.76017165 |
| 117 | Bifid scrotum (HP:0000048) | 1.75776364 |
| 118 | * Cardiovascular calcification (HP:0011915) | 1.75166913 |
| 119 | Facial shape deformation (HP:0011334) | 1.69002731 |
| 120 | Potter facies (HP:0002009) | 1.69002731 |
| 121 | Abnormal delivery (HP:0001787) | 1.62603721 |
| 122 | Gangrene (HP:0100758) | 1.56488320 |
| 123 | Abnormality of carpal bone ossification (HP:0006257) | 1.53816507 |
| 124 | Abnormal urine phosphate concentration (HP:0012599) | 1.53006515 |
| 125 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.51869498 |
| 126 | Petechiae (HP:0000967) | 1.51762134 |
| 127 | Neonatal hypoglycemia (HP:0001998) | 1.50561969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.36969917 |
| 2 | FGFR4 | 4.51914673 |
| 3 | SIK1 | 4.22351172 |
| 4 | ERN1 | 4.16205925 |
| 5 | INSRR | 2.84693968 |
| 6 | ERBB4 | 2.81058794 |
| 7 | TAOK3 | 2.76289992 |
| 8 | PIK3CA | 2.46684275 |
| 9 | MST4 | 2.21669438 |
| 10 | MAP2K4 | 2.19725379 |
| 11 | MST1R | 2.19551699 |
| 12 | LMTK2 | 2.13921945 |
| 13 | MYLK | 2.02891784 |
| 14 | PKN2 | 2.02186059 |
| 15 | EIF2AK1 | 2.00475159 |
| 16 | MAPK11 | 1.87755809 |
| 17 | ACVR1B | 1.79883963 |
| 18 | MAP3K2 | 1.79372698 |
| 19 | MAPKAPK3 | 1.72400017 |
| 20 | FLT3 | 1.71264225 |
| 21 | TRIB3 | 1.68535567 |
| 22 | PIK3CG | 1.65125047 |
| 23 | WNK3 | 1.62476380 |
| 24 | LATS1 | 1.59598362 |
| 25 | TYK2 | 1.56334758 |
| 26 | MAP3K12 | 1.55760596 |
| 27 | ABL2 | 1.51124818 |
| 28 | PTK6 | 1.44414098 |
| 29 | FER | 1.44173151 |
| 30 | WNK4 | 1.42295608 |
| 31 | DAPK2 | 1.41206930 |
| 32 | BMX | 1.40306384 |
| 33 | STK38L | 1.37058338 |
| 34 | NEK9 | 1.32561749 |
| 35 | FRK | 1.32005402 |
| 36 | PINK1 | 1.27237216 |
| 37 | MAP3K7 | 1.25792405 |
| 38 | AKT3 | 1.25020821 |
| 39 | FGFR2 | 1.24542200 |
| 40 | EPHA2 | 1.24457647 |
| 41 | NLK | 1.21605591 |
| 42 | JAK2 | 1.17671743 |
| 43 | KDR | 1.17489370 |
| 44 | GRK6 | 1.16755430 |
| 45 | NTRK3 | 1.16698524 |
| 46 | OXSR1 | 1.16479991 |
| 47 | BRSK2 | 1.15301028 |
| 48 | PRKAA2 | 1.13196408 |
| 49 | FGFR1 | 1.05694365 |
| 50 | MAP2K3 | 1.02355336 |
| 51 | MAP3K14 | 0.98342525 |
| 52 | TBK1 | 0.96834394 |
| 53 | ERBB2 | 0.95640731 |
| 54 | PRKCZ | 0.92954228 |
| 55 | EPHB1 | 0.92724114 |
| 56 | CDK12 | 0.91589425 |
| 57 | JAK1 | 0.90749559 |
| 58 | MAPK4 | 0.90548148 |
| 59 | MAP3K3 | 0.90350436 |
| 60 | MAPK15 | 0.88425771 |
| 61 | ZAP70 | 0.87645036 |
| 62 | MAP3K10 | 0.87196591 |
| 63 | MET | 0.84834471 |
| 64 | TIE1 | 0.83616626 |
| 65 | STK39 | 0.82406287 |
| 66 | SGK3 | 0.81929530 |
| 67 | GSK3A | 0.77867472 |
| 68 | MAPK12 | 0.76816479 |
| 69 | DYRK1B | 0.76446212 |
| 70 | PRKACG | 0.74801992 |
| 71 | TNK2 | 0.74583299 |
| 72 | MAP3K11 | 0.73214352 |
| 73 | PRKAA1 | 0.72342820 |
| 74 | FGR | 0.72009833 |
| 75 | SGK223 | 0.71324557 |
| 76 | SGK494 | 0.71324557 |
| 77 | CDK6 | 0.70773638 |
| 78 | PRKG1 | 0.67570040 |
| 79 | SGK2 | 0.66973133 |
| 80 | PDGFRA | 0.66809931 |
| 81 | CAMK2G | 0.66099383 |
| 82 | CSK | 0.64204118 |
| 83 | PDK3 | 0.63778499 |
| 84 | PDK4 | 0.63778499 |
| 85 | MAP2K6 | 0.63507494 |
| 86 | PTK2 | 0.63102595 |
| 87 | EPHA3 | 0.63042911 |
| 88 | IRAK3 | 0.62604250 |
| 89 | TGFBR2 | 0.62377859 |
| 90 | BMPR2 | 0.61017178 |
| 91 | MAP3K1 | 0.59131848 |
| 92 | RIPK1 | 0.59002279 |
| 93 | CAMKK2 | 0.57646917 |
| 94 | PDPK1 | 0.57618347 |
| 95 | PRKG2 | 0.57519626 |
| 96 | CAMK1D | 0.55831216 |
| 97 | CAMK1G | 0.55113890 |
| 98 | CSNK1E | 0.52693982 |
| 99 | MUSK | 0.50703559 |
| 100 | MAPK7 | 0.50277206 |
| 101 | FGFR3 | 0.49627173 |
| 102 | PRKCQ | 0.48330297 |
| 103 | SRC | 0.48032235 |
| 104 | PRKACA | 0.47610894 |
| 105 | IKBKE | 0.47292764 |
| 106 | CSNK1G1 | 0.46883241 |
| 107 | CSNK1D | 0.46602018 |
| 108 | CSF1R | 0.46404636 |
| 109 | SGK1 | 0.45033384 |
| 110 | STK3 | 0.44880288 |
| 111 | ILK | 0.44374579 |
| 112 | EPHA4 | 0.44031990 |
| 113 | PRKCB | 0.43958495 |
| 114 | IGF1R | 0.41534410 |
| 115 | GRK1 | 0.38739187 |
| 116 | MAP3K5 | 0.38592068 |
| 117 | MAP3K13 | 0.38312325 |
| 118 | PRKCG | 0.37956440 |
| 119 | TAOK2 | 0.37553671 |
| 120 | NEK1 | 0.37519955 |
| 121 | MAP2K1 | 0.37350963 |
| 122 | MATK | 0.36831167 |
| 123 | STK24 | 0.36503806 |
| 124 | TEC | 0.35619038 |
| 125 | PDK1 | 0.35503825 |
| 126 | WNK1 | 0.35476048 |
| 127 | PRKCE | 0.34923166 |
| 128 | PKN1 | 0.33985613 |
| 129 | RET | 0.33215649 |
| 130 | MTOR | 0.32911660 |
| 131 | CDK4 | 0.32375980 |
| 132 | MAP3K6 | 0.32238517 |
| 133 | ICK | 0.31789826 |
| 134 | IRAK2 | 0.30804030 |
| 135 | EGFR | 0.30412155 |
| 136 | CAMK4 | 0.30116855 |
| 137 | PBK | 0.28264679 |
| 138 | IRAK1 | 0.27880454 |
| 139 | PDK2 | 0.26805320 |
| 140 | STK38 | 0.26532616 |
| 141 | PRKCA | 0.26338403 |
| 142 | CSNK1G2 | 0.25986073 |
| 143 | PAK3 | 0.25745315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.37962717 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.49886542 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.42279754 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39837321 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04226092 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.73018579 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72183132 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62675591 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58030525 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.57621942 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50904006 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49660086 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.33022620 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.29959337 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.16119716 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07991177 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.06164010 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87752827 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87181325 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85529064 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84996818 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84336542 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81576746 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.77374248 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75998056 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74729520 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70208912 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68440644 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65366851 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62544743 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61883033 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60439709 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58808760 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57228253 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.52587894 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46530393 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41819803 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40612902 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34759786 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29655291 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27914158 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24226309 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.22096334 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21790800 |
| 45 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20387596 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19684228 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15626101 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14434946 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.12686864 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05606244 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05512224 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02416859 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97238291 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96370666 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92201819 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91773350 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.86967136 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86370819 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84885536 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75000619 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74652392 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71332648 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69202502 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64867321 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58325200 |
| 66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47259966 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45581142 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44725685 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.31760403 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31146854 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.30428489 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29264692 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24108418 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22527979 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.21419122 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20543176 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20334659 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16112427 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16012163 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12463713 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08120183 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.06402238 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.02486562 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01486548 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.00562066 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | -0.2406834 |
| 87 | Lysosome_Homo sapiens_hsa04142 | -0.2317695 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2178893 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | -0.2081821 |
| 90 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2013742 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1907248 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1889252 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1815651 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1749003 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1747691 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1654205 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1460728 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1279738 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1277244 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1272159 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1222927 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1202596 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1146469 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1084102 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0966600 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0945952 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0867459 |
| 108 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0553048 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | -0.0410693 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0278067 |

